
    
      The purpose of the clinical study is to obtain clinical data on the CardioMech Mitral Valve
      Repair System (MVRS) in patients diagnosed with moderate to severe (≥3+) or severe (≥4+),
      symptomatic, degenerative mitral regurgitation and who are determined to be at intermediate
      or high surgical risk for mitral valve repair, as assessed by the site's multidisciplinary
      heart team.
    
  